These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma. Ito T, Nakayama T, Ito M, Naito S, Kanematsu T, Sekine I. Mod Pathol; 1998 Feb; 11(2):209-15. PubMed ID: 9504693 [Abstract] [Full Text] [Related]
5. Expression of the bcl-2 gene and its significance in human pancreatic carcinoma. Sun CY, Wang BL, Hu CQ, Peng RY, Gao YB, Gu QY, Wang DW. Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):306-8. PubMed ID: 14612291 [Abstract] [Full Text] [Related]
7. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. Ito T, Ito M, Shiozawa J, Naito S, Kanematsu T, Sekine I. Mod Pathol; 1999 Jul; 12(7):669-74. PubMed ID: 10430270 [Abstract] [Full Text] [Related]
8. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man. Marks WH, Ohlsson K, Polling A. Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569 [Abstract] [Full Text] [Related]
12. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Linder S, Castaños-Velez E, von Rosen A, Biberfeld P. Hepatogastroenterology; 2001 Sep 03; 48(41):1321-7. PubMed ID: 11677955 [Abstract] [Full Text] [Related]
13. p27 Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value. Feakins RM, Ghaffar AH. Hum Pathol; 2003 Apr 03; 34(4):385-90. PubMed ID: 12733121 [Abstract] [Full Text] [Related]
15. Alpha-1-antitrypsin (AAT) and its stimulation in the liver of PiMZ phenotype individuals. A "recruitment-secretory block" ("R-SB") phenomenon. Callea F, Fevery J, Massi G, Lievens C, de Groote J, Desmet VJ. Liver; 1984 Oct 03; 4(5):325-37. PubMed ID: 6334213 [Abstract] [Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival. Giaginis C, Katsamangou E, Tsourouflis G, Zizi-Serbetzoglou D, Kouraklis G, Theocharis S. Med Sci Monit; 2009 May 03; 15(5):BR148-56. PubMed ID: 19396032 [Abstract] [Full Text] [Related]
17. Variant of intraductal carcinoma (with scant mucin production) is of main pancreatic duct origin: a clinicopathological study of four patients. Suda K, Hirai S, Matsumoto Y, Mogaki M, Oyama T, Mitsui T, Fujibayashi M, Kumazawa K, Kajiwara T. Am J Gastroenterol; 1996 Apr 03; 91(4):798-800. PubMed ID: 8677955 [Abstract] [Full Text] [Related]
18. Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment. Zelvyte I, Ohlsson B, Axelson J, Janciauskiene S. Anticancer Res; 2003 Apr 03; 23(3B):2267-73. PubMed ID: 12894502 [Abstract] [Full Text] [Related]
19. Demonstration of alpha 1-antitrypsin in hepatomas. Reintoft I, Hägerstrand I. Arch Pathol Lab Med; 1979 Sep 03; 103(10):495-8. PubMed ID: 223516 [Abstract] [Full Text] [Related]